3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
16
Myelodysplastic Syndromes
3
Leukemia, Monocytic, Acute
3
Leukemia
3
Recurrence
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Myeloproliferative Disorders
2
Thrombocythemia, Essential
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Polycythemia Vera
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Leukemia, Myeloid
1
Leukemia, Megakaryoblastic, Acute
1
Leukemia, Lymphoid
1
Leukemia, Erythroblastic, Acute
1
Leukemia, Biphenotypic, Acute
1
Disease
1
Congenital Abnormalities
1
Burkitt Lymphoma
1
Interventions
Mycophenolic Acid
25
fludarabine phosphate
21
Whole-Body Irradiation
21
Cyclophosphamide
21
Cyclosporine
16
Tacrolimus
15
Peripheral Blood Stem Cell Transplantation
15
Busulfan
14
fludarabine
11
Cord Blood Stem Cell Transplantation
9
Methotrexate
8
Melphalan
8
Granulocyte Colony-Stimulating Factor
8
Cytarabine
8
Antilymphocyte Serum
8
Filgrastim
7
Thiotepa
6
Etoposide
6
sargramostim
4
merphos
4
Radiotherapy
4
Drug Therapy
4
Cyclosporins
4
Azacitidine
4
thymoglobulin
3
Vorinostat
3
Sirolimus
3
Lenalidomide
3
Idarubicin
3
tipifarnib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Anemia, Refractory, with Excess of Blasts
×
CPX-351
×
Clear all
No trials found.